4/4/2022
20 million for the Vaud scale-up company Nanolive
The Vaud-based scale-up Nanolive, a leading live cell imaging and analysis company, announces today that it has successfully completed the initial closing of US $20 million in the Series C-1 equity financing round of investment, led by a US-based and NASDAQ listed life science investor, and Taiwania Capital, the leading life science venture capital company based in Taiwan.